In this study of 195 patients with unexplained infertility and confirmed endometriosis, those who underwent preoperative Receptiva BCL6 testing had significantly fewer affected anatomical sites and a lower proportion of high-stage disease compared to those who did not undergo testing. This evidence concerns the gene BCL6 and endometriosis.